Sky Century Investment (SKYI) Cash from Investing Activities (2024 - 2026)
Sky Century Investment's (SKYI) quarterly Cash from Investing Activities came in at -$30080.0 in Q2 2026, up 49.19% year-on-year from -$20162.3 in Q2 2025, and down 67.11% on a QoQ basis from -$18000.0 in Q4 2025.
Sky Century Investment (SKYI) Cash from Investing Activities (2024 - 2026) Analysis & Trends
Sky Century Investment (SKYI) has 3 years of Cash from Investing Activities data on file, last reported at -$30080.0 in Q2 2026.
- On a quarterly basis, Cash from Investing Activities rose 49.19% year-over-year to -$30080.0 in Q2 2026; TTM through May 2026 was -$65480.0, a 36.57% increase from a year earlier, with the FY2025 full-year figure at -$92140.0, down 223.3% from the prior year.
- Cash from Investing Activities for Q2 2026 stood at -$30080.0, down from -$18000.0 in the prior quarter.
- Over the last five years, Cash from Investing Activities for SKYI reached as high as -$15540.0 in Q1 2025 and fell as low as -$59200.0 in Q2 2025.
- Historically, Cash from Investing Activities has averaged -$28120.0 across 3 years, with a median of -$23250.0 in 2024.
- Across the five-year window, Cash from Investing Activities jumped 38.95% in 2025 and jumped 49.19% in 2026, its largest moves.
- Year by year, Cash from Investing Activities stood at -$28500.0 in 2024, then soared by 36.84% to -$18000.0 in 2025, then plunged by 67.11% to -$30080.0 in 2026.
- Per Business Quant data, the three most recent Cash from Investing Activities figures were -$30080.0 in Q2 2026, -$18000.0 in Q4 2025, and -$17400.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 229.00 Mn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | -87.00 Mn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | -369.95 Mn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 743.70 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 277.40 Mn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | -506.20 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | -60.00 Mn |
| 10 | Sky Century Investment | 944,514.46 | 944,250.46 | 26,045.00 | -30,080.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -30,080.00 |
| May 31, 2026 | -30,080.00 |
| Nov 30, 2025 | -18,000.00 |
| Nov 30, 2025 | -18,000.00 |
| Aug 31, 2025 | -17,400.00 |
| Aug 31, 2025 | -17,400.00 |
| May 31, 2025 | -59,200.00 |
| May 31, 2025 | -59,200.00 |
| Feb 28, 2025 | -15,540.00 |
| Feb 28, 2025 | -15,540.00 |
| Aug 31, 2024 | -28,500.00 |
| Aug 31, 2024 | -28,500.00 |